Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy.
作者信息
Chhablani Jay Kumar, Narula Ritesh, Narayanan Raja
出版信息
Indian J Ophthalmol. 2013 Mar;61(3):136-8. doi: 10.4103/0301-4738.109390.
Abstract
摘要
相似文献
1
Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy.玻璃体内注射贝伐单抗单药治疗初治息肉样脉络膜血管病变。
Indian J Ophthalmol. 2013 Mar;61(3):136-8. doi: 10.4103/0301-4738.109390.
2
Short-term effectiveness of intravitreal bevacizumab vs. ranibizumab injections for patients with polypoidal choroidal vasculopathy.玻璃体内注射贝伐单抗与雷珠单抗治疗息肉状脉络膜血管病变患者的短期疗效
Korean J Ophthalmol. 2012 Jun;26(3):157-62. doi: 10.3341/kjo.2012.26.3.157. Epub 2012 May 22.
3
Efficacy of combined photodynamic therapy and intravitreal bevacizumab injection versus photodynamic therapy alone in polypoidal choroidal vasculopathy.联合光动力疗法和玻璃体内贝伐单抗注射与单纯光动力疗法治疗息肉状脉络膜血管病变的疗效比较。
Retina. 2011 Oct;31(9):1827-34. doi: 10.1097/IAE.0b013e318214d01e.
4
Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.玻璃体内注射贝伐单抗联合光动力疗法治疗息肉状脉络膜血管病变的疗效。
Am J Ophthalmol. 2010 Jul;150(1):48-54.e1. doi: 10.1016/j.ajo.2010.02.008.
5
One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.眼内注射bevacizumab（阿瓦斯汀）治疗息肉样脉络膜血管病变的一年疗效观察。
Retina. 2011 May;31(5):846-56. doi: 10.1097/IAE.0b013e3181f84fdf.
6
Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy.玻璃体内注射贝伐单抗和雷珠单抗治疗息肉样脉络膜血管病变。
Eye (Lond). 2012 Mar;26(3):426-33. doi: 10.1038/eye.2011.324. Epub 2011 Dec 16.
7
COMPARISON OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHIC CHANGES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ALONE OR IN COMBINATION WITH PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY.抗血管内皮生长因子治疗单独或联合光动力疗法治疗息肉状脉络膜血管病变后光学相干断层扫描血管造影的变化比较。
Retina. 2018 Sep;38(9):1675-1687. doi: 10.1097/IAE.0000000000001776.
8
Two-year outcome after combination therapy for polypoidal choroidal vasculopathy: comparison with photodynamic monotherapy and anti-vascular endothelial growth factor monotherapy.息肉样脉络膜血管病变的联合治疗两年后结果：与光动力单独治疗和抗血管内皮生长因子单独治疗的比较。
Ophthalmologica. 2014;231(2):86-93. doi: 10.1159/000354546. Epub 2013 Oct 17.
9
Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.黄斑中心凹下脉络膜厚度作为息肉样脉络膜血管病变抗血管内皮生长因子治疗反应的预测指标。
Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1497-1503. doi: 10.1007/s00417-015-3221-x. Epub 2015 Dec 1.
10
Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.低强度光动力疗法联合玻璃体内贝伐单抗治疗息肉状脉络膜血管病变。
Am J Ophthalmol. 2012 May;153(5):873-882.e2. doi: 10.1016/j.ajo.2011.09.031. Epub 2012 Jan 20.
引用本文的文献
1
Polypoidal choroidal vasculopathy-characteristics and response to treatment with bevacizumab in caucasian patients.息肉样脉络膜血管病变——白种人患者的特征及对贝伐单抗治疗的反应
Int J Retina Vitreous. 2022 Nov 22;8(1):82. doi: 10.1186/s40942-022-00432-x.
2
Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.特发性息肉状脉络膜血管病变：文献复习及现行治疗方法的临床更新。
Int Ophthalmol. 2021 Feb;41(2):753-765. doi: 10.1007/s10792-020-01620-0. Epub 2020 Oct 20.
3
Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy.比较玻璃体内注射雷珠单抗和贝伐单抗单药治疗初治息肉状脉络膜血管病变。
Indian J Ophthalmol. 2019 Jul;67(7):1114-1118. doi: 10.4103/ijo.IJO_638_18.
4
Polypoidal choroidal vasculopathy: An update on current management and review of literature.息肉样脉络膜血管病变：当前治疗进展及文献综述
Taiwan J Ophthalmol. 2019 Apr-Jun;9(2):72-92. doi: 10.4103/tjo.tjo_35_18.
5
Polypoidal choroidal vasculopathy: a comprehensive clinical update.息肉样脉络膜血管病变：临床综合进展
Ther Adv Ophthalmol. 2019 Feb 27;11:2515841419831152. doi: 10.1177/2515841419831152. eCollection 2019 Jan-Dec.
6
Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy.息肉样脉络膜血管病变两种不同血管造影亚型的康柏西普治疗1年结果比较。
Chin Med J (Engl). 2016 Nov 5;129(21):2610-2616. doi: 10.4103/0366-6999.192779.
7
Polypoidal choroidal vasculopathy: an update on therapeutic approaches.息肉样脉络膜血管病变：治疗方法的最新进展
J Ophthalmic Vis Res. 2013 Oct;8(4):359-71.
8
Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy.玻璃体内注射贝伐单抗单药治疗息肉状脉络膜血管病变
Indian J Ophthalmol. 2013 Nov;61(11):684. doi: 10.4103/0301-4738.123149.
本文引用的文献
1
Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.光动力疗法联合维替泊芬与玻璃体内贝伐单抗治疗息肉状脉络膜血管病变。
Am J Ophthalmol. 2010 Jun;149(6):947-954.e1. doi: 10.1016/j.ajo.2009.12.038. Epub 2010 Mar 26.
2
Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results.康柏西普眼用注射液治疗息肉状脉络膜血管病变：6 个月结果。
Br J Ophthalmol. 2010 Mar;94(3):297-301. doi: 10.1136/bjo.2008.150029. Epub 2009 Sep 1.
3
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.玻璃体腔内注射贝伐单抗（阿瓦斯汀）联合或不联合光动力疗法治疗息肉样脉络膜血管病变。
Br J Ophthalmol. 2008 May;92(5):661-6. doi: 10.1136/bjo.2007.135103. Epub 2008 Mar 20.
4
Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.维替泊芬光动力疗法治疗症状性息肉状脉络膜血管病变：一项前瞻性病例系列研究的一年结果
Ophthalmology. 2004 Aug;111(8):1576-84. doi: 10.1016/j.ophtha.2003.12.056.
Zotero 插件